{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T03:43:14Z","timestamp":1793245394936,"version":"4.5.0"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T00:00:00Z","timestamp":1645747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Department of Neurosurgery"},{"name":"Hermelin Brain Tumor Center"},{"DOI":"10.13039\/100007278","name":"Henry Ford Health System","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007278","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Henry Ford Hospital","award":["A30935"],"award-info":[{"award-number":["A30935"]}]},{"name":"Henry Ford Hospital","award":["A30957"],"award-info":[{"award-number":["A30957"]}]},{"name":"Henry Ford Hospital","award":["202199"],"award-info":[{"award-number":["202199"]}]},{"name":"Kimble Family Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>DNA methylation abnormalities are pervasive in pituitary neuroendocrine tumors (PitNETs). The feasibility to detect methylome alterations in circulating cell-free DNA (cfDNA) has been reported for several central nervous system (CNS) tumors but not across PitNETs. The aim of the study was to use the liquid biopsy (LB) approach to detect PitNET-specific methylation signatures to differentiate these tumors from other sellar diseases.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We profiled the cfDNA methylome (EPIC array) of 59 serum and 41 plasma LB specimens from patients with PitNETs and other CNS diseases (sellar tumors and other pituitary non-neoplastic diseases, lower-grade gliomas, and skull-base meningiomas) or nontumor conditions, grouped as non-PitNET.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Our results indicated that despite quantitative and qualitative differences between serum and plasma cfDNA composition, both sources of LB showed that patients with PitNETs presented a distinct methylome landscape compared to non-PitNETs. In addition, LB methylomes captured epigenetic features reported in PitNET tissue and provided information about cell-type composition. Using LB-derived PitNETs-specific signatures as input to develop machine-learning predictive models, we generated scores that distinguished PitNETs from non-PitNETs conditions, including sellar tumor and non-neoplastic pituitary diseases, with accuracies above ~93% in independent cohort sets.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Our results underpin the potential application of methylation-based LB profiling as a noninvasive approach to identify clinically relevant epigenetic markers to diagnose and potentially impact the prognostication and management of patients with PitNETs.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/neuonc\/noac050","type":"journal-article","created":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T20:16:51Z","timestamp":1645647411000},"page":"1126-1139","source":"Crossref","is-referenced-by-count":34,"title":["Detection of tumor-specific DNA methylation markers in the blood of patients with pituitary neuroendocrine tumors"],"prefix":"10.1093","volume":"24","author":[{"given":"Grayson A","family":"Herrgott","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System , Detroit, Michigan , USA"},{"name":"Department of Neurosurgery, Omics Laboratory, Henry Ford Health System , Detroit, Michigan , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karam P","family":"Asmaro","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System , Detroit, Michigan , USA"},{"name":"Department of Neurosurgery, Omics Laboratory, Henry Ford Health System , Detroit, Michigan , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Wells","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System , Detroit, Michigan , USA"},{"name":"Department of Neurosurgery, Omics Laboratory, Henry Ford Health System , Detroit, Michigan , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thais S","family":"Sabedot","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System , Detroit, Michigan , USA"},{"name":"Department of Neurosurgery, Omics Laboratory, Henry Ford Health System , Detroit, Michigan , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tathiane M","family":"Malta","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System , Detroit, Michigan , USA"},{"name":"Department of Neurosurgery, Omics Laboratory, Henry Ford Health System , Detroit, Michigan , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maritza S","family":"Mosella","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System , Detroit, Michigan , USA"},{"name":"Department of Neurosurgery, Omics Laboratory, Henry Ford Health System , Detroit, Michigan , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Nelson","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System , Detroit, Michigan , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Scarpace","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System , Detroit, Michigan , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill S","family":"Barnholtz-Sloan","sequence":"additional","affiliation":[{"name":"Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine , Cleveland, Ohio , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew E","family":"Sloan","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, University Hospitals of Cleveland , Cleveland, Ohio , USA"},{"name":"Case Comprehensive Cancer Center , Cleveland, Ohio , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warren R","family":"Selman","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, University Hospitals of Cleveland , Cleveland, Ohio , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana C","family":"deCarvalho","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System , Detroit, Michigan , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laila M","family":"Poisson","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Henry Ford Health System , Detroit, Michigan , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abir","family":"Mukherjee","sequence":"additional","affiliation":[{"name":"Department of Pathology, Henry Ford Health System , Detroit, Michigan , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4285-2722","authenticated-orcid":false,"given":"Adam M","family":"Robin","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System , Detroit, Michigan , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6057-7176","authenticated-orcid":false,"given":"Ian Y","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System , Detroit, Michigan , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Snyder","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System , Detroit, Michigan , USA"},{"name":"Department of Neurosurgery, Omics Laboratory, Henry Ford Health System , Detroit, Michigan , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0667-8106","authenticated-orcid":false,"given":"Tobias","family":"Walbert","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System , Detroit, Michigan , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Rosenblum","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System , Detroit, Michigan , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Mikkelsen","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System , Detroit, Michigan , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arti","family":"Bhan","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Henry Ford Health System , Detroit, Michigan , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7377-4782","authenticated-orcid":false,"given":"John","family":"Craig","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology, Skull Base, Pituitary and Endoscopy Center, Henry Ford Health System , Detroit, Michigan , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Kalkanis","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System , Detroit, Michigan , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Rock","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System , Detroit, Michigan , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4051-8114","authenticated-orcid":false,"given":"Houtan","family":"Noushmehr","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System , Detroit, Michigan , USA"},{"name":"Department of Neurosurgery, Omics Laboratory, Henry Ford Health System , Detroit, Michigan , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1625-0015","authenticated-orcid":false,"given":"Ana Valeria","family":"Castro","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System , Detroit, Michigan , USA"},{"name":"Department of Neurosurgery, Omics Laboratory, Henry Ford Health System , Detroit, Michigan , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,2,25]]},"reference":[{"issue":"4","key":"2022070112575061700_CIT0001","doi-asserted-by":"crossref","first-page":"C5","DOI":"10.1530\/ERC-17-0004","article-title":"From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal","volume":"24","author":"Asa","year":"2017","journal-title":"Endocr Relat Cancer."},{"issue":"Suppl 5","key":"2022070112575061700_CIT0002","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1093\/neuonc\/noz150","article-title":"CBTRUS Statistical Report: primary brain and other central nervous system tumors diagnosed in the United States in 2012-2016","volume":"21","author":"Ostrom","year":"2019","journal-title":"Neuro Oncol."},{"issue":"5","key":"2022070112575061700_CIT0003","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1001\/jama.2016.19699","article-title":"Diagnosis and treatment of pituitary adenomas: a review","volume":"317","author":"Molitch","year":"2017","journal-title":"JAMA."},{"issue":"3","key":"2022070112575061700_CIT0004","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s12022-017-9498-z","article-title":"Overview of the 2017 WHO classification of pituitary tumors","volume":"28","author":"Mete","year":"2017","journal-title":"Endocr Pathol."},{"issue":"5","key":"2022070112575061700_CIT0005","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/neup.12291","article-title":"The clinicopathological features of pituicytoma and the differential diagnosis of sellar glioma","volume":"36","author":"Wang","year":"2016","journal-title":"Neuropathology."},{"issue":"1","key":"2022070112575061700_CIT0006","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0889-8529(05)70058-X","article-title":"Differential diagnosis of sellar masses","volume":"28","author":"Freda","year":"1999","journal-title":"Endocrinol Metab Clin North Am."},{"issue":"2","key":"2022070112575061700_CIT0007","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1017\/cjn.2015.301","article-title":"Sellar masses: an epidemiological study","volume":"43","author":"Al-Dahmani","year":"2016","journal-title":"Can J Neurol Sci."},{"issue":"2","key":"2022070112575061700_CIT0008","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1158\/1078-0432.CCR-19-2533","article-title":"Clinical utility of plasma cell-free DNA in adult patients with newly diagnosed glioblastoma: a pilot prospective study","volume":"26","author":"Bagley","year":"2020","journal-title":"Clin Cancer Res."},{"issue":"9","key":"2022070112575061700_CIT0009","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1093\/neuonc\/noab023","article-title":"A serum-based DNA methylation assay provides accurate detection of glioma","volume":"23","author":"Sabedot","year":"2021","journal-title":"Neuro Oncol."},{"issue":"7732","key":"2022070112575061700_CIT0010","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/s41586-018-0703-0","article-title":"Sensitive tumour detection and classification using plasma cell-free DNA methylomes","volume":"563","author":"Shen","year":"2018","journal-title":"Nature."},{"issue":"7","key":"2022070112575061700_CIT0011","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/neuonc\/noz061","article-title":"DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management","volume":"21","author":"Nassiri","year":"2019","journal-title":"Neuro Oncol."},{"key":"2022070112575061700_CIT0012","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3389\/fendo.2019.00615","article-title":"Evaluation of the possibility to detect circulating tumor DNA from pituitary adenoma","volume":"10","author":"Megnis","year":"2019","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"4","key":"2022070112575061700_CIT0013","doi-asserted-by":"crossref","first-page":"e96178","DOI":"10.1371\/journal.pone.0096178","article-title":"A pilot genome-scale profiling of DNA methylation in sporadic pituitary macroadenomas: association with tumor invasion and histopathological subtype","volume":"9","author":"Ling","year":"2014","journal-title":"PLoS One."},{"key":"2022070112575061700_CIT0014","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.mce.2018.01.020","article-title":"DNA methylation profiling in nonfunctioning pituitary adenomas","volume":"473","author":"Kober","year":"2018","journal-title":"Mol Cell Endocrinol."},{"issue":"17","key":"2022070112575061700_CIT0015","doi-asserted-by":"crossref","first-page":"4126","DOI":"10.1158\/1078-0432.CCR-17-2206","article-title":"The epigenomic landscape of pituitary adenomas reveals specific alterations and differentiates among acromegaly, Cushing\u2019s disease and endocrine-inactive subtypes","volume":"24","author":"Salomon","year":"2018","journal-title":"Clin Cancer Res."},{"issue":"7697","key":"2022070112575061700_CIT0016","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nature26000","article-title":"DNA methylation-based classification of central nervous system tumours","volume":"555","author":"Capper","year":"2018","journal-title":"Nature."},{"issue":"1","key":"2022070112575061700_CIT0017","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11060-016-2139-4","article-title":"Differential DNA methylome profiling of nonfunctioning pituitary adenomas suggesting tumour invasion is correlated with cell adhesion","volume":"129","author":"Gu","year":"2016","journal-title":"J Neurooncol."},{"issue":"1","key":"2022070112575061700_CIT0018","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ccell.2019.11.002","article-title":"Pangenomic classification of pituitary neuroendocrine tumors","volume":"37","author":"Neou","year":"2020","journal-title":"Cancer Cell."},{"issue":"10","key":"2022070112575061700_CIT0019","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/S1470-2045(16)30297-2","article-title":"Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis","volume":"17","author":"Moran","year":"2016","journal-title":"Lancet Oncol."},{"issue":"2","key":"2022070112575061700_CIT0020","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.cell.2018.03.022","article-title":"Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer","volume":"173","author":"Hoadley","year":"2018","journal-title":"Cell."},{"issue":"28","key":"2022070112575061700_CIT0021","doi-asserted-by":"crossref","first-page":"7414","DOI":"10.1073\/pnas.1703577114","article-title":"DNA methylation markers for diagnosis and prognosis of common cancers","volume":"114","author":"Hao","year":"2017","journal-title":"Proc Natl Acad Sci USA."},{"issue":"8","key":"2022070112575061700_CIT0022","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1093\/neuonc\/noab044","article-title":"DNA methylation-based signatures classify sporadic pituitary tumors according to clinicopathological features","volume":"23","author":"Mosella","year":"2021","journal-title":"Neuro Oncol."},{"issue":"7","key":"2022070112575061700_CIT0023","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1038\/s41591-020-0932-2","article-title":"Detection and discrimination of intracranial tumors using plasma cell-free DNA methylomes","volume":"26","author":"Nassiri","year":"2020","journal-title":"Nat Med."},{"issue":"3","key":"2022070112575061700_CIT0024","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.cell.2015.12.028","article-title":"Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma","volume":"164","author":"Ceccarelli","year":"2016","journal-title":"Cell."},{"issue":"5","key":"2022070112575061700_CIT0025","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S1470-2045(17)30155-9","article-title":"DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis","volume":"18","author":"Sahm","year":"2017","journal-title":"Lancet Oncol."},{"issue":"1","key":"2022070112575061700_CIT0026","doi-asserted-by":"crossref","first-page":"5068","DOI":"10.1038\/s41467-018-07466-6","article-title":"Comprehensive human cell-type methylation atlas reveals origins of circulating cell-free DNA in health and disease","volume":"9","author":"Moss","year":"2018","journal-title":"Nat Commun."},{"issue":"8","key":"2022070112575061700_CIT0027","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1093\/nar\/gkv1507","article-title":"TCGAbiolinks: an R\/Bioconductor package for integrative analysis of TCGA data","volume":"44","author":"Colaprico","year":"2016","journal-title":"Nucleic Acids Res."},{"issue":"7","key":"2022070112575061700_CIT0028","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1093\/nar\/gkt090","article-title":"Low-level processing of Illumina Infinium DNA methylation beadarrays","volume":"41","author":"Triche","year":"2013","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"2022070112575061700_CIT0029","first-page":"e22","article-title":"Comprehensive characterization, annotation and innovative use of Infinium DNA methylation BeadChip probes","volume":"45","author":"Zhou","year":"2017","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"2022070112575061700_CIT0030","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","article-title":"Causal analysis approaches in ingenuity pathway analysis","volume":"30","author":"Kr\u00e4mer","year":"2014","journal-title":"Bioinformatics."},{"issue":"1","key":"2022070112575061700_CIT0031","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"Huang","year":"2009","journal-title":"Nat Protoc."},{"issue":"11","key":"2022070112575061700_CIT0032","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1093\/bioinformatics\/bty902","article-title":"ELMER v.2: an R\/Bioconductor package to reconstruct gene regulatory networks from DNA methylation and transcriptome profiles","volume":"35","author":"Silva","year":"2019","journal-title":"Bioinformatics."},{"issue":"1","key":"2022070112575061700_CIT0033","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1038\/s41467-018-05570-1","article-title":"Pan-cancer deconvolution of tumour composition using DNA methylation","volume":"9","author":"Chakravarthy","year":"2018","journal-title":"Nat Commun."},{"issue":"1","key":"2022070112575061700_CIT0034","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13040-021-00244-z","article-title":"The Matthews correlation coefficient (MCC) is more reliable than balanced accuracy, bookmaker informedness, and markedness in two-class confusion matrix evaluation","volume":"14","author":"Chicco","year":"2021","journal-title":"BioData Min."},{"issue":"3","key":"2022070112575061700_CIT0035","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s10654-011-9561-x","article-title":"Sensitivity \u00d7 PPV is a recognized test called the clinical utility index (CUI+)","volume":"26","author":"Mitchell","year":"2011","journal-title":"Eur J Epidemiol."},{"issue":"1","key":"2022070112575061700_CIT0036","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s13148-019-0779-x","article-title":"Early detection of the major male cancer types in blood-based liquid biopsies using a DNA methylation panel","volume":"11","author":"Const\u00e2ncio","year":"2019","journal-title":"Clin Epigenetics."},{"issue":"1","key":"2022070112575061700_CIT0037","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13059-017-1191-5","article-title":"CancerLocator: non-invasive cancer diagnosis and tissue-of-origin prediction using methylation profiles of cell-free DNA","volume":"18","author":"Kang","year":"2017","journal-title":"Genome Biol."},{"issue":"10","key":"2022070112575061700_CIT0038","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1056\/NEJMra1810772","article-title":"Pituitary-tumor endocrinopathies","volume":"382","author":"Melmed","year":"2020","journal-title":"N Engl J Med."},{"issue":"10","key":"2022070112575061700_CIT0039","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1042\/CS20190145","article-title":"Mucin O-glycosylating enzyme GALNT2 facilitates the malignant character of glioma by activating the EGFR\/PI3K\/Akt\/mTOR axis","volume":"133","author":"Sun","year":"2019","journal-title":"Clin Sci."},{"issue":"1","key":"2022070112575061700_CIT0040","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13072-019-0291-8","article-title":"Identification of a pituitary ER\u03b1-activated enhancer triggering the expression of Nr5a1, the earliest gonadotrope lineage-specific transcription factor","volume":"12","author":"Pacini","year":"2019","journal-title":"Epigenetics Chromatin."},{"issue":"2","key":"2022070112575061700_CIT0041","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s10528-015-9709-6","article-title":"Molecular mechanisms underlying pituitary pathogenesis","volume":"54","author":"Sapochnik","year":"2016","journal-title":"Biochem Genet."},{"issue":"2","key":"2022070112575061700_CIT0042","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s12020-013-0093-x","article-title":"Prolactinoma ErbB receptor expression and targeted therapy for aggressive tumors","volume":"46","author":"Cooper","year":"2014","journal-title":"Endocrine."},{"key":"2022070112575061700_CIT0043","doi-asserted-by":"crossref","first-page":"4698167","DOI":"10.1155\/2017\/4698167","article-title":"TXNRD1 is an unfavorable prognostic factor for patients with hepatocellular carcinoma","volume":"2017","author":"Fu","year":"2017","journal-title":"Biomed Res Int."},{"key":"2022070112575061700_CIT0044","doi-asserted-by":"crossref","first-page":"100078","DOI":"10.1016\/j.bdq.2018.12.003","article-title":"Considerations and quality controls when analyzing cell-free tumor DNA","volume":"17","author":"Johansson","year":"2019","journal-title":"Biomol Detect Quantif."},{"issue":"1","key":"2022070112575061700_CIT0045","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41698-021-00198-9","article-title":"A DNA methylation-based liquid biopsy for triple-negative breast cancer","volume":"5","author":"Cristall","year":"2021","journal-title":"npj Precis Oncol."},{"issue":"12","key":"2022070112575061700_CIT0046","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1002\/pros.24025","article-title":"Development and initial clinical correlation of a DNA methylation-based blood test for prostate cancer","volume":"80","author":"Carson","year":"2020","journal-title":"Prostate."}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/advance-article-pdf\/doi\/10.1093\/neuonc\/noac050\/43057201\/noac050.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/24\/7\/1126\/44371583\/noac050.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/24\/7\/1126\/44371583\/noac050.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T12:59:01Z","timestamp":1656680341000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article\/24\/7\/1126\/6536850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,25]]},"references-count":46,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,2,25]]},"published-print":{"date-parts":[[2022,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/neuonc\/noac050","relation":{},"ISSN":["1522-8517","1523-5866"],"issn-type":[{"value":"1522-8517","type":"print"},{"value":"1523-5866","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,7,1]]},"published":{"date-parts":[[2022,2,25]]}}}